Neuraclick welcomes biotech veteran daniel m. bradbury as strategic and metabolic programs advisor

San diego, sept. 23, 2025 (globe newswire) -- neuraclick, inc., an innovative, preclinical-stage biopharmaceutical company reimagining patient health through the development of novel, long-acting neurotherapeutics, today announced the appointment of industry veteran and biotech executive daniel m.
EQ Ratings Summary
EQ Quant Ranking